68 results
Page 3 of 4
PRE 14A
usxnl
2 Apr 19
Preliminary proxy
4:29pm
POS AM
430cvoihylv15ojyim5
28 Feb 19
Prospectus update (post-effective amendment)
4:54pm
POSASR
7lizhd8g3 z88p
28 Feb 19
Automatic shelf registration (post-effective amendment)
4:17pm
424B5
2vm9y90vtw037zizyc
17 Aug 18
Prospectus supplement for primary offering
4:05pm
S-3ASR
p502pbleldw
2 Jul 18
Automatic shelf registration
4:08pm
8-K
EX-99.1
3wx09n
24 May 18
Entry into a Material Definitive Agreement
7:10am
8-K
EX-1.1
qsx8clbmg26sfgs1
3 May 18
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
5:02pm
424B5
b64ksq
3 May 18
Prospectus supplement for primary offering
5:00pm
424B5
3j5a3xwb aan4yu
1 May 18
Prospectus supplement for primary offering
4:18pm
424B5
5wc x2419nyh63elz6e
26 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
6c9283syq0x7
24 Apr 17
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
xi8ooq bbz
8 Jan 15
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
12:00am
424B5
wi1x2
7 Jan 15
Prospectus supplement for primary offering
12:00am
S-3ASR
0gpacxrykn0s zfq6
5 Jan 15
Automatic shelf registration
12:00am
424B5
r66rfbag9tuizlfl1
5 Jan 15
Prospectus supplement for primary offering
12:00am
10-K
w0s d6y15r68j2ce
21 Mar 14
Annual report
12:00am
424B4
i10ejf77x
7 Nov 13
Prospectus supplement with pricing info
12:00am